Remco Nagel

The Netherlands Cancer Institute — Netherlands

Biochemistry, Genetics and Molecular Biology · Life Sciences

21h-index5.8kcitations117works6.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(28), FOXO transcription factor regulation(27), MicroRNA in disease regulation(15), Cancer-related molecular mechanisms research(14), Genetic factors in colorectal cancer(12)

Publications117 total

Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation
Immunity·2025· 7 citedOpen Access
Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer
Nucleic Acids Research·2024· 6 citedOpen Access
Supplementary Table 2 from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Supplementary Table 5 from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Supplementary Figure 1A from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023Open Access
Supplementary Figure 4 from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Supplementary Table 6 from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Supplementary Table 2 from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Data from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023Open Access
Supplementary Figure 1C + D from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023Open Access
Supplementary Figure 2 from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Supplementary Tables 1-6 from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023Open Access
Supplementary Figure 5 from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023Open Access
Supplementary Figure 2 from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023Open Access
Supplementary Figure 2 from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Supplementary Figure 5 from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023Open Access
Supplementary Figure Legends from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Supplementary Table 6 from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Supplementary Methods from Genome-wide siRNA Screen Identifies the Radiosensitizing Effect of Downregulation of MASTL and FOXM1 in NSCLC
2023Open Access
Data from Inhibition of the Replication Stress Response Is a Synthetic Vulnerability in SCLC That Acts Synergistically in Combination with Cisplatin
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Reuven Agami(28), Ruud H. Brakenhoff(14), Abhijeet Pataskar(13), Carlos le Sage(11), Onno B. Bleijerveld(11), Marijke Stigter‐van Walsum(11), Ida H. van der Meulen(11), Victor W. van Beusechem(11), Maarten Altelaar(9), Julien Champagne(8), Natalie Proost(8), Sander R. Piersma(8), Thang V. Pham(8), Connie R. Jiménez(8), Anton Berns(7), Marijke Buijze(7), Marieke van de Ven(7), Sanne R. Martens‐de Kemp(6), Boudewijn J.M. Braakhuis(6), Alejandro P. Ugalde(6)